|
Volume
21 Number 9
September 2019
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
21, Year 2019 >
Number 9, September
|
|
|
|
|
|
Lowe
S, Bhat KP, Olar A.
Current
clinical management of patients with glioblastoma.
Cancer
Rep
(Hoboken).
2019 Sep 4. 2019;2(6):e1216. doi: 10.1002/cnr2.1216.
Review.
_
|
|
|
|
|
|
|
|
|
|
▲
|
|
Chi
AS et
al, PDQ Adult Treatment Editorial Board.
Adult
Central Nervous System Tumors Treatment (PDQ®): Patient
Version.
PDQ
Cancer Inf Summ. 2019 Sep 9. NCBI Bookshelf:
NBK66023. _
|
|
|
|
Cohen KJ, et al, PDQ Pediatric Treatment Editorial Board.
Childhood Brain and Spinal Cord Tumors Treatment Overview
(PDQ®): Health Professional Version.
PDQ
Cancer Inf Summ. 2019 Sep 9. NCBI Bookshelf:
NBK66018. _
|
|
|
|
Cuccurullo V, Di Stasio GD, Cascini GL, Gatta G, Bianco C.
The
Molecular Effects of Ionizing Radiations on Brain Cells: Radiation
Necrosis vs. Tumor Recurrence.
Diagnostics
(Basel). 2019 Sep 24. 2019;9(4). doi: 10.3390/diagnostics9040127.
_
|
|
|
|
Fares J, Fares MY, Fares Y.
Natural killer cells in the
brain tumor microenvironment: Defining a new era in
neuro-oncology.
Surg
Neurol Int. 2019 Mar 26. 2019;10:43. doi:
10.25259/SNI-97-2019. _
|
|
|
|
Foster JB, Madsen PJ, Hegde M, Ahmed N, Cole KA, Maris JM, Resnick
AC, Storm PB, Waanders AJ.
Immunotherapy for pediatric
brain tumors: past and present.
Neuro
Oncol. 2019 Aug 24. 2019;21(10):1226-1238. doi:
10.1093/neuonc/noz077. _
|
|
|
|
Georges JF, Valeri A, Wang H, Brooking A, Kakareka M, Cho SS,
Al-Atrache Z, Bamimore M, Osman H, Ifrach J, Yu S, Li C, Appelt D,
Lee JYK, Nakaji P, Brill K, Yocom S.
Delta-Aminolevulinic
Acid-Mediated Photodiagnoses in Surgical Oncology: A Historical
Review of Clinical Trials.
Front
Surg. 2019 Sep 4. 2019;6:45. doi:
10.3389/fsurg.2019.00045. _
|
|
|
|
Kwon S, Yoo KH, Sym SJ, Khang D.
Mesenchymal stem cell
therapy assisted by nanotechnology: a possible combinational
treatment for brain tumor and central nerve regeneration.
Int
J Nanomedicine. 2019 Jul 29. 2019;14:5925-5942.
doi: 10.2147/IJN.S217923. _
|
|
|
|
Lu
VM, Rechberger JS, Himes BT, Daniels DJ.
The
100 Most-Cited Articles About Convection-Enhanced Delivery to the
Brain: A Bibliometric Analysis.
World
Neurosurg. 2019 Sep;129:497-502.e6⍈.
doi: 10.1016/j.wneu.2019.05.179⍈.
Epub 2019 May 29. PMID: 31150865⍈.
Bibliometric analysis. ⍈
|
|
|
|
Mahon BZ, Miozzo M, Pilcher WH.
Direct electrical
stimulation mapping of cognitive functions in the human brain.
Cogn
Neuropsychol. 2019 Sep 12. 2019;36(3-4):97-102.
doi: 10.1080/02643294.2019.1630375. _
|
|
|
|
Qazi MA, Bakhshinyan D, Singh SK.
Deciphering brain tumor
heterogeneity, one cell at a time.
Nat
Med. 2019 Sep 20. doi: 10.1038/s41591-019-0605-1.
_
|
|
|
|
Ritchey AK, et al, PDQ
Pediatric Treatment Editorial Board.
Childhood Brain and
Spinal Cord Tumors Treatment Overview (PDQ®): Health
Professional Version.
PDQ
Cancer Inf Summ. 2019 Aug 29. NCBI Bookshelf:
NBK65913. _
|
|
|
|
Treglia G, Muoio B, Trevisi G, Mattoli MV, Albano D, Bertagna F,
Giovanella L.
Diagnostic Performance and Prognostic Value
of PET/CT with Different Tracers for Brain Tumors: A Systematic
Review of Published Meta-Analyses.
Int
J Mol Sci. 2019 Sep 20;20(19). doi:
10.3390/ijms20194669. _
|
|
|
|
Vienne-Jumeau A, Tafani C, Ricard D.
Environmental risk
factors of primary brain tumors: A review.
Rev
Neurol (Paris). 2019 Sep 13. doi:
10.1016/j.neurol.2019.08.004. _
|
|
|
|
▲
|
|
Bhavya B, Anand CR, Madhusoodanan UK, Rajalakshmi P, Krishnakumar
K, Easwer HV, Deepti AN, Gopala S.
To be Wild or Mutant:
Role of Isocitrate Dehydrogenase 1 (IDH1) and 2-Hydroxy Glutarate
(2-HG) in Gliomagenesis and Treatment Outcome in Glioma.
Cell
Mol Neurobiol. 2019 Sep 4. doi:
10.1007/s10571-019-00730-3. _
|
|
|
|
Di Ieva A, Magnussen JS, McIntosh J, Mulcahy MJ, Pardey M, Choi C.
Magnetic Resonance Spectroscopic Assessment of IDH Status
in gliomas: The New Frontiers of Spectrobiopsy in
Neurodiagnostics.
World
Neurosurg. 2019 Sep 14. doi:
10.1016/j.wneu.2019.09.040. _
|
|
|
|
Feng F, Zhang M, Yang C, Heng X, Wu X.
The dual roles of
autophagy in gliomagenesis and clinical therapy strategies based
on autophagic regulation mechanisms.
Biomed
Pharmacother. 2019 Sep 18. 2019;120:109441. doi:
10.1016/j.biopha.2019.109441. _
|
|
|
|
Huang LE.
Friend or foe-IDH1 mutations in glioma 10 years
on.
Carcinogenesis.
2019 Sep 3. doi: 10.1093/carcin/bgz134. _
|
|
|
|
Lei YY, Li YT, Hu QL, Wang J, Sui AX.
Prognostic impact
of neutrophil-to-lymphocyte ratio in gliomas: a systematic review
and meta-analysis.
World
J Surg Oncol. 2019 Aug 31. 2019;17(1):152. doi:
10.1186/s12957-019-1686-5. _
|
|
|
|
|
|
de Zwart PL, van Dijken BR, Holtman GA, Stormezand GN, Dierckx RA,
van Laar PJ, van der Hoorn A.
Diagnostic accuracy of
positron emission tomography tracers for the differentiation of
tumor progression from treatment-related changes in high-grade
glioma: a systematic review and meta-analysis.
J
Nucl Med. 2019 Sep 20. doi:
10.2967/jnumed.119.233809. _
|
|
|
|
Goodarzi A, Garza N, Lechpammer M, Anthony R, Zwienenberg M.
The
molecular oncology of bilateral high-grade thalamic astrocytomas
in children.
Childs
Nerv Syst. 2019 Sep 14. doi:
10.1007/s00381-019-04372-0. _
|
|
|
|
|
|
Bitterman DS, MacDonald SM, Yock TI, Tarbell NJ, Wright KD, Chi
SN, Marcus KJ, Haas-Kogan DA.
Revisiting the Role of
Radiation Therapy for Pediatric Low-Grade Glioma.
J
Clin Oncol. 2019 Sep 9. 2019:JCO1901270. doi:
10.1200/JCO.19.01270. _
|
|
|
|
Ghaffari-Rafi A, Samandouras G.
Effect of Treatment
Modalities on Progression-Free Survival and Overall Survival, in
Molecularly Subtyped WHO Grade II Diffuse Gliomas: A Systematic
Review.
World
Neurosurg. 2019 Aug 29. doi:
10.1016/j.wneu.2019.08.111. _
|
|
|
|
▲
|
|
|
|
|
|
Berghoff A, van den Bent M.
How I treat anaplastic glioma
without 1p/19q codeletion.
ESMO
Open. 2019 Aug 20. 2019;4(Suppl 2):e000534. doi:
10.1136/esmoopen-2019-000534. _
|
|
|
|
|
|
Akhaddar A, Hall W, Boucetta M.
Subgaleal and brain
abscesses due to Salmonella enteritidis
following craniotomy for giant cell glioblastoma multiforme: A
case report and literature review.
Surg
Neurol Int. 2019 Mar 26. 2019;10:37. doi:
10.25259/SNI-31-2019. _
|
|
|
|
Bartek J Jr, Alattar AA, Dhawan S, Ma J, Koga T, Nakaji P,
Dusenbery KE, Chen CC.
Receipt of brachytherapy is an
independent predictor of survival in glioblastoma in the
Surveillance, Epidemiology, and End Results database.
J
Neurooncol. 2019 Aug 30. 2019;145(1):75-83. doi:
10.1007/s11060-019-03268-y. _
|
|
|
|
Fecci PE, Sampson JH.
The current state of immunotherapy
for gliomas: an eye toward the future.
J
Neurosurg. 2019 Sep 1. 2019;131(3):657-666. doi:
10.3171/2019.5.JNS181762. _
|
|
|
|
Krivoshapkin AL, Gaytan AS, Salim N, Abdullaev OA, Sergeev GS,
Marmazeev IV, Cesnulis E, Killeen T, Goryainov SA.
Re-Resection
And Intraoperative Radiotherapy For Malignant Gliomas Of The
Brain: A History And Review Of Current Techniques.
World
Neurosurg. 2019 Sep 16. doi:
10.1016/j.wneu.2019.09.037. _
|
|
|
|
Matarredona ER, Pastor AM.
Neural
Stem Cells of the Subventricular Zone as the Origin of Human
Glioblastoma Stem Cells. Therapeutic Implications.
Front
Oncol. 2019 Aug 20;9:779⍈.
doi: 10.3389/fonc.2019.00779⍈.
PMID: 31482066⍈.
Review. ⍈
|
|
|
|
Montemurro N.
Glioblastoma Multiforme and Genetic
Mutations: The Issue Is Not Over Yet. An Overview of the Current
Literature.
J
Neurol Surg A Cent Eur Neurosurg. 2019 Sep 24. doi:
10.1055/s-0039-1688911. _
|
|
|
|
Policicchio D, Doda A, Muggianu G, Dipellegrini G, Boccaletti R.
Ethical and therapeutic dilemmas in glioblastoma
management during pregnancy: Two case reports and review of the
literature.
Surg
Neurol Int. 2019 Mar 26. 2019;10:41. doi:
10.25259/SNI-86-2019. _
|
|
|
|
Strobel H, Baisch T, Fitzel R, Schilberg K, Siegelin MD,
Karpel-Massler G, Debatin KM, Westhoff MA.
Temozolomide
and Other Alkylating Agents in Glioblastoma Therapy.
Biomedicines.
2019 Sep 9. 2019;7(3). doi: 10.3390/biomedicines7030069.
_
|
|
|
|
|
|
Khan DA, Laghari AA, Bari ME, Shamim MS.
Treatment
options for paediatric brainstem gliomas.
J
Pak Med Assoc. 2019 Sep;69(9):1400-1402.
_
|
|
|
|
El-Khouly FE, Veldhuijzen van Zanten SEM, Santa-Maria Lopez V,
Hendrikse NH, Kaspers GJL, Loizos G, Sumerauer D, Nysom K,
Pruunsild K, Pentikainen V, Thorarinsdottir HK, Rutkauskiene G,
Calvagna V, Drogosiewicz M, Dragomir M, Deak L, Kitanovski L, von
Bueren AO, Kebudi R, Slavc I, Jacobs S, Jadrijevic-Cvrlje F,
Entz-Werle N, Grill J, Kattamis A, Hauser P, Pears J, Biassoni V,
Massimino M, Lopez Aguilar E, Torsvik IK, Joao Gil-da-Costa M,
Kumirova E, Cruz-Martinez O, Holm S, Bailey S, Hayden T, Thomale
UW, Janssens GOR, Kramm CM, van Vuurden DG.
Diagnostics
and treatment of diffuse intrinsic pontine glioma: where do we
stand?
J
Neurooncol. 2019 Sep 14. 2019;145(1):177-184. doi:
10.1007/s11060-019-03287-9. _
|
|
|
|
Rechberger JS, Lu VM, Zhang L, Power EA, Daniels DJ.
Clinical
trials for diffuse intrinsic pontine glioma: the current state of
affairs.
Childs
Nerv Syst. 2019 Sep 6. doi:
10.1007/s00381-019-04363-1. _
|
|
|
|
Ritchey AK, et al., PDQ
Pediatric Treatment Editorial Board.
Childhood Brain Stem
Glioma Treatment (PDQ®): Patient Version.
PDQ
Cancer Inf Summ. 2019 Sep 6. NCBI Bookshelf:
NBK65856. _
|
|
|
|
▲
|
|
|
|
|
|
Cohen KJ, et al, PDQ Pediatric Treatment Editorial Board.
Childhood Ependymoma Treatment (PDQ®): Health
Professional Version.
PDQ
Cancer Inf Summ. 2019 Sep 9. NCBI Bookshelf:
NBK65935. _
|
|
|
|
▲
|
|
|
|
|
|
Cohen KJ et al., PDQ Pediatric Treatment Editorial Board.
Childhood Medulloblastoma and Other Central Nervous
System Embryonal Tumors Treatment (PDQ®): Health Professional
Version.
PDQ
Cancer Inf Summ. 2019 Sep 9. NCBI Bookshelf:
NBK65981. _
|
|
|
|
Dasgupta A, Gupta T.
MRI-based prediction of molecular
subgrouping in medulloblastoma: images speak louder than words.
Oncotarget.
2019 Aug 6. 2019;10(47):4805-4807. doi: 10.18632/oncotarget.27097.
_
|
|
|
|
Li K, Duan WC, Zhao HB, Wang L, Wang WW, Zhan YB, Sun T, Zhang FJ,
Yu B, Bai YH, Wang YM, Ji YC, Zhou JQ, Liu XZ, Zhang ZF, Zhang ZY.
Preoperative Neutrophil to Lymphocyte Ratio and Platelet
to Lymphocyte Ratio are Associated with the Prognosis of Group 3
and Group 4 Medulloblastoma.
Sci
Rep. 2019 Sep 13. 2019;9(1):13239. doi:
10.1038/s41598-019-49733-6. _
|
|
|
|
Vinchon M, Leblond P.
Medulloblastoma: Clinical
presentation.
Neurochirurgie.
2019 Sep 5. doi: 10.1016/j.neuchi.2019.04.006.
_
|
|
|
|
▲
|
|
Brodbelt AR, Barclay ME, Greenberg D, Williams M, Jenkinson MD,
Karabatsou K.
The outcome of patients with surgically
treated meningioma in England: 1999-2013. A cancer registry data
analysis.
Br
J Neurosurg. 2019 Sep 17. 2019;1-7. doi:
10.1080/02688697.2019.1661965. _
|
|
|
|
|
|
Memon A, Rogers I, Paudyal P, Sundin J.
Dental x-rays and
the risk of thyroid cancer and meningioma: A systematic review and
meta-analysis of current epidemiological evidence.
Thyroid.
2019 Sep 10. doi: 10.1089/thy.2019.0105. _
|
|
|
|
Truong VT, Tran DDT, Dang CT.
Collision Occurrence of
Meningioma and Astrocytoma: A Case Report and Literature Review.
Asian
J Neurosurg. 2019 Aug 2. 2019;14(3):938-942. doi:
10.4103/ajns.AJNS_97_19. _
|
|
|
|
Likar R, Koestenberger M,
Stultschnig M, Nahler G.
Concomitant
Treatment of Malignant Brain Tumours With CBD - A Case Series and
Review of the Literature.
Anticancer
Res. 2019 Sep 30, 2019;39(10):5797-5801→.
doi: 10.21873/anticanres.13783→.
PMID: 31570484→.
Case
report, Review.
→
|
|
|
|
|
|
|
|
|
